↓ Skip to main content

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

Overview of attention for article published in Breast Cancer Research, November 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent
10 patents
f1000
1 research highlight platform

Citations

dimensions_citation
122 Dimensions

Readers on

mendeley
103 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342
Published in
Breast Cancer Research, November 2006
DOI 10.1186/bcr1622
Pubmed ID
Authors

Lyndsay N Harris, Gloria Broadwater, Nancy U Lin, Alexander Miron, Stuart J Schnitt, David Cowan, Jonathan Lara, Ira Bleiweiss, Donald Berry, Matthew Ellis, Daniel F Hayes, Eric P Winer, Lynn Dressler

Abstract

The response to paclitaxel varies widely in metastatic breast cancer. We analyzed data from CALGB 9342, which tested three doses of paclitaxel in women with advanced disease, to determine whether response and outcomes differed according to HER2, hormone receptor, and p53 status.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 2 2%
United States 1 <1%
Germany 1 <1%
Unknown 99 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 20%
Student > Ph. D. Student 16 16%
Student > Master 11 11%
Other 10 10%
Professor > Associate Professor 9 9%
Other 18 17%
Unknown 18 17%
Readers by discipline Count As %
Medicine and Dentistry 37 36%
Biochemistry, Genetics and Molecular Biology 17 17%
Agricultural and Biological Sciences 11 11%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Economics, Econometrics and Finance 4 4%
Other 9 9%
Unknown 21 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2019.
All research outputs
#3,418,699
of 25,394,764 outputs
Outputs from Breast Cancer Research
#379
of 2,054 outputs
Outputs of similar age
#12,043
of 167,956 outputs
Outputs of similar age from Breast Cancer Research
#4
of 14 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,054 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,956 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.